Cuberes-Altisent, Maria Rosa,Sola - Carandell, Lluis,Garcia - Couceiro, Urko
申请号：
AU2010323116
公开号：
AU2010323116B2
申请日:
2010.11.25
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.
